Pharma and Life Science Tools: A Quality Growth Revival (Robeco)
Pharmaceuticals sector equities are emerging from an extended period in which capital has chased hyperscalers and…
Pharmaceuticals sector equities are emerging from an extended period in which capital has chased hyperscalers and…
In a market increasingly shaped by passive ownership, benchmark constraints, and limited active capital, that…
While forecasts for AI-related investment may vary considerably depending on assumptions, it is expected that…
Bottlenecks may result in persistently high compute prices. Investment opportunities in energized compute capacity…